These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7744595)

  • 1. Fatal neutropenic colitis complicating successful chemotherapy for small cell lung cancer: a case report.
    Stein M; Zalik M; Drumea K; Lachter J; Militianu D; Haim N
    Isr J Med Sci; 1995; 31(2-3):194-6. PubMed ID: 7744595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal chemotherapy associated Clostridium difficile infection--a case report.
    Wong AS; Lam CS; Tambyah PA
    Singapore Med J; 2001 May; 42(5):214-6. PubMed ID: 11513059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neutropenic enterocolitis].
    Rexroth G; Altmannsberger HM; Hassenstein EO; Rösch W
    Z Gastroenterol; 1998 Jan; 36(1):27-33. PubMed ID: 9531687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature.
    Avigan D; Richardson P; Elias A; Demetri G; Shapiro M; Schnipper L; Wheeler C
    Cancer; 1998 Aug; 83(3):409-14. PubMed ID: 9690531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neutropenic colitis. A case report].
    Sinibaldi G; Covizzi M; Corbascio D
    Minerva Chir; 1997; 52(7-8):975-7. PubMed ID: 9411303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.
    Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A
    Lung Cancer; 2009 Aug; 65(2):251-3. PubMed ID: 19346026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of neutropenic enterocolitis (typhlitis) by ultrasonography.
    Gootenberg JE; Abbondanzo SL
    Am J Pediatr Hematol Oncol; 1987; 9(3):222-7. PubMed ID: 3314548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
    J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
    Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
    Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutropenic enterocolitis].
    Kau M; Jensen S
    Ugeskr Laeger; 1993 Jul; 155(29):2251-4. PubMed ID: 8328093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer.
    Banerji U; Ashley S; Coward J; Hughes S; Zee Y; Benepal T; Norton A; Eisen T; O'Brien M
    Lung Cancer; 2006 Dec; 54(3):371-7. PubMed ID: 17049670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic-associated colitis in Chulalongkorn University Hospital.
    Sriuranpong V; Voravud N
    J Med Assoc Thai; 1995 Aug; 78(8):424-30. PubMed ID: 7561566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of small cell lung cancer].
    Komiya T; Takada M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA; Al Omari A; Murry DJ; Case D
    Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant chemotherapy of lung cancer].
    Yamaguchi Y; Urabe N; Momiki S; Obata S; Ogawa T; Kimura H
    Rinsho Kyobu Geka; 1987; 7(5):448-52. PubMed ID: 9301798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.